SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-053008
Filing Date
2023-10-17
Accepted
2023-10-17 18:42:44
Documents
1
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4197
  Complete submission text file 0001209191-23-053008.txt   5605
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Issuer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TURNSTONE BIOLOGICS CORP. 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address
Ramanan Venkat (Reporting) CIK: 0001979596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41747 | Film No.: 231330590